YBX1 and cancer: In addition, the translocation of YB-1 from the cytoplasm to nucleus has been reported, mainly, upon treatment with a DNA-damaging drug; these data support the idea that YB-1 has nuclear-specific functions in cancer cells (Stein et al., 2001; Fujita et al., 2005; Sorokin et al., 2005).